173 related articles for article (PubMed ID: 11160881)
1. Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes.
Shea ME; Hiasa H
Nucleic Acids Res; 2001 Feb; 29(3):614-21. PubMed ID: 11160881
[TBL] [Abstract][Full Text] [Related]
2. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes.
Shea ME; Hiasa H
J Biol Chem; 1999 Aug; 274(32):22747-54. PubMed ID: 10428858
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of the UvrD helicase on topoisomerase-quinolone-DNA ternary complexes.
Shea ME; Hiasa H
J Biol Chem; 2000 May; 275(19):14649-58. PubMed ID: 10799552
[TBL] [Abstract][Full Text] [Related]
4. The RuvAB branch migration complex can displace topoisomerase IV.quinolone.DNA ternary complexes.
Shea ME; Hiasa H
J Biol Chem; 2003 Nov; 278(48):48485-90. PubMed ID: 13679378
[TBL] [Abstract][Full Text] [Related]
5. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex.
Hiasa H; Yousef DO; Marians KJ
J Biol Chem; 1996 Oct; 271(42):26424-9. PubMed ID: 8824300
[TBL] [Abstract][Full Text] [Related]
6. DNA gyrase-mediated wrapping of the DNA strand is required for the replication fork arrest by the DNA gyrase-quinolone-DNA ternary complex.
Hiasa H; Shea ME
J Biol Chem; 2000 Nov; 275(44):34780-6. PubMed ID: 11053451
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
Khodursky AB; Cozzarelli NR
J Biol Chem; 1998 Oct; 273(42):27668-77. PubMed ID: 9765303
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of quinolone action. A drug-induced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV.
Marians KJ; Hiasa H
J Biol Chem; 1997 Apr; 272(14):9401-9. PubMed ID: 9083078
[TBL] [Abstract][Full Text] [Related]
9. The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions.
Hiasa H
Biochemistry; 2002 Oct; 41(39):11779-85. PubMed ID: 12269820
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with temozolomide and methoxyamine: blocking apurininc/pyrimidinic site repair coupled with targeting topoisomerase IIalpha.
Yan L; Bulgar A; Miao Y; Mahajan V; Donze JR; Gerson SL; Liu L
Clin Cancer Res; 2007 Mar; 13(5):1532-9. PubMed ID: 17332299
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky AB; Zechiedrich EL; Cozzarelli NR
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11801-5. PubMed ID: 8524852
[TBL] [Abstract][Full Text] [Related]
12. Immunodetection of human topoisomerase I-DNA covalent complexes.
Patel AG; Flatten KS; Peterson KL; Beito TG; Schneider PA; Perkins AL; Harki DA; Kaufmann SH
Nucleic Acids Res; 2016 Apr; 44(6):2816-26. PubMed ID: 26917015
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg(2+) to the second metal binding site.
Oppegard LM; Schwanz HA; Towle TR; Kerns RJ; Hiasa H
Biochim Biophys Acta; 2016 Mar; 1860(3):569-75. PubMed ID: 26723176
[TBL] [Abstract][Full Text] [Related]
14. DNA abasic lesions in a different light: solution structure of an endogenous topoisomerase II poison.
Cline SD; Jones WR; Stone MP; Osheroff N
Biochemistry; 1999 Nov; 38(47):15500-7. PubMed ID: 10569932
[TBL] [Abstract][Full Text] [Related]
15. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo.
Hong G; Kreuzer KN
Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238
[TBL] [Abstract][Full Text] [Related]
16. Base excision repair intermediates as topoisomerase II poisons.
Wilstermann AM; Osheroff N
J Biol Chem; 2001 Dec; 276(49):46290-6. PubMed ID: 11591703
[TBL] [Abstract][Full Text] [Related]
17. The interaction of Escherichia coli topoisomerase IV with DNA.
Peng H; Marians KJ
J Biol Chem; 1995 Oct; 270(42):25286-90. PubMed ID: 7559669
[TBL] [Abstract][Full Text] [Related]
18. Apurinic sites are position-specific topoisomerase II poisons.
Kingma PS; Osheroff N
J Biol Chem; 1997 Jan; 272(2):1148-55. PubMed ID: 8995415
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
Aoyama M; Grabowski DR; Dubyak GR; Constantinou AI; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):727-33. PubMed ID: 9841887
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of Escherichia coli topoisomerase IV. III. Identification of a region of parE involved in covalent catalysis.
Bahng S; Mossessova E; Nurse P; Marians KJ
J Biol Chem; 2000 Feb; 275(6):4112-7. PubMed ID: 10660571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
